XML 103 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities    
Net profit (loss) $ (6,928,575) $ 1,907,042
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 2,083,489 1,767,584
Provision for doubtful debts 443,020 176,961
Write-down of inventories 557,668 730,446
Share-based compensation 432,785 189,002
(Gain) loss on disposal of property, plant and equipment 236,360 (1,137)
Gain on disposal of patented proprietary technology (12,296,776)
Changes in operating assets and liabilities:    
Trade accounts and bills receivable 4,008,929 27,035,867
Inventories (2,254,761) (530,345)
Prepayments and other receivables 1,735,548 394,178
Trade accounts and bills payable (12,128,474) (1,226,192)
Accrued expenses and other payables 1,357,021 (368,702)
Trade receivable from and payables to former subsidiaries (3,449,078) (8,637,203)
Net cash provided by (used in) operating activities (13,906,068) 9,140,725
Cash flows from investing activities    
Proceeds on disposal of property, plant and equipment 13,319
Purchases of property, plant and equipment and construction in progress (1,998,476) (6,574,347)
Net cash used in investing activities (1,998,476) (6,561,028)
Cash flows from financing activities    
Capital injection from non-controlling interests 118,850 26,864
Proceeds from bank borrowings 24,233,796
Repayment of bank borrowings (3,545,966) (19,411,531)
Proceeds from issue of promissory note 1,250,000
Borrowings from unrelated parties 6,397,925 76,544
Repayment of borrowings from unrelated parties (145,739) (44,091)
Borrowings from related parties 431,630 10,696,243
Repayment of borrowings from related parties (535,967) (8,206,464)
Borrowings from shareholders 4,080,681
Repayment of earnest money to shareholders (760,721)
Net cash provided by financing activities 7,290,693 7,371,361
Effect of exchange rate changes on cash and cash equivalents and restricted cash (494,264) (1,052,946)
Net increase (decrease) in cash and cash equivalents and restricted cash (9,108,115) 8,898,112
Cash and cash equivalents and restricted cash at the beginning of period 17,689,493 10,748,713
Cash and cash equivalents and restricted cash at the end of period 8,581,378 19,646,825
Supplemental non-cash investing and financing activities:    
Transfer of construction in progress to property, plant and equipment 777,324 7,236,709
Proceeds on disposal of patented proprietary technology offset against amount due to a former subsidiary 13,034,583
Issuance of common stock to investors - offset short-term borrowings from unrelated parties 15,056,304
Issuance of common stock to investors - offset construction cost payable (note 1) 3,317,021
Cash paid during the period for:    
Income taxes
Interest, net of amounts capitalized $ 1,087,390 $ 721,029